MINH TRINH: Open Payments
NPI 1477132116 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 60 payments from 16 companies in 2025. Trend: 2023 $1,476 · 2024 $1,623 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $411 |
| Amgen Inc. | 20 | $229 |
| AstraZeneca Pharmaceuticals LP | 7 | $211 |
| Novo Nordisk Inc | 4 | $64 |
| Astellas Pharma US Inc | 2 | $43 |
| Lilly USA, LLC | 1 | $28 |
| Renalytix AI, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: OTEZLA, AIRSUPRA, Veozah, REPATHA, FARXIGA, MOUNJARO, Livdelzi, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across AZ — which companies pay providers there.
